(no title)
zonethundery | 1 year ago
2- Yeah, the one 'reasonable' complaint of IPR critics is the different evidentiary bar for litigation vs IPR.
IANAL but it's difficult to find a member of the patent bar outside of pharma/npe's that supports either bill.
AlbertCory|1 year ago
that's it exactly. Pharma really should have its own patent regime, or at least, software & pharma should not have the same one.